Bronchopulmonary Dysplasia (BPD)
Supplements studied for bronchopulmonary dysplasia (BPD).
Overview
Supplement research for bronchopulmonary dysplasia (BPD) in premature infants has focused on several agents, with mixed results. Vitamin A given by injection appears to have the strongest evidence among top supplements here, with nine studies suggesting it may lower BPD risk in low-birth-weight preterm infants at certain doses; lower doses or other forms may not show the same effect.
By contrast, N-Acetyl Cysteine (NAC) given directly into the lungs, oral Vitamin E, and Fish Oil have not shown clear benefit in available trials, including a large preterm infant study of fish oil. Lutein lacks sufficient evidence to judge. See the heatmap and evidence reviews below for supplement-by-supplement detail.
Effect graph
Subscribe to view effect graphs
Interactive visualisations of ranked conditions and clinical benefit with purchase guidance.
Already a subscriber? Sign in
Relevant supplements heatmap
Relevant supplements sorted by DEX Score.
Subscribe to view effect heatmaps
See effect size, evidence strength, and trust at a glance for every condition.
Already a subscriber? Sign in
SupplementDEX Database
9 supplements for and rated at least stars. All purchase bands. No minimum star filter.
Subscribe to access the SupplementDEX Database
Read this and 2,600+ other evidence reviews on our practitioner plan.
Already a subscriber? Sign in
Evidence visualised
Subscribe to view condition evidence
Visual summaries of supplement evidence ranked by condition.
Already a subscriber? Sign in